ROSEMARIE SCHMANDT to Carcinoma, Endometrioid
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Carcinoma, Endometrioid.
Connection Strength
0.256
-
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study. Gynecol Oncol. 2016 Dec; 143(3):466-471.
Score: 0.112
-
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. Cancer. 2014 Nov 15; 120(22):3457-68.
Score: 0.096
-
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol. 2004 Oct; 95(1):32-6.
Score: 0.049